Disease Info Card

Proliferative Diabetic Retinopathy

Information about Proliferative Diabetic Retinopathy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Proliferative Diabetic Retinopathy

Most recent studies have shown that Proliferative Diabetic Retinopathy shares some biological mechanisms with blind-vision, cataract, diabetes-mellitus, diabetes-mellitus-insulin-dependent, diabetes-mellitus-non-insulin-dependent, diabetic-retinopathy, disorder-of-eye, edema, epiretinal-membrane, glaucoma, hemorrhage, macular-retinal-edema, nonproliferative-diabetic-retinopathy, pathologic-neovascularization, proliferative-vitreoretinopathy, retinal-detachment, retinal-diseases, retinal-neovascularization, retinopathy-proliferative, vitreous-hemorrhage.

Among the many pathways, these few ones have gauged particular interests from scientists studying Proliferative Diabetic Retinopathy, and have been seen in publications frequently: Angiogenesis, Cell Adhesion, Cell Death, Cell Growth, Cell Migration, Cell Proliferation, Coagulation, Delamination, Drug Resistance, Endothelial Cell Proliferation, Excretion, Localization, Pathogenesis, Platelet Aggregation, Reflex, Secretion, Segmentation, Transport, Tube Formation, Wound Healing

Quite a number of genes have been found to play important roles in Proliferative Diabetic Retinopathy, such as ABCB6, ACE, ALB, C4BPA, CARD14, FN1, GATA3, GFAP, HGF, IGF1, IL6, INS, PNPLA2, PRDX2, PRNP, PVR, SERPINF1, TNF, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.